ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$7.35 USD
+2.24 (43.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.58 +0.23 (3.13%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.19 |
Last EPS Surprise | -5.56% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.68 |
Next Year | -0.45 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03M | 0.53M | 9.68M | 84.68M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.03M | 0.53M | 9.68M | 84.68M |
Low Estimate | 0.03M | 0.53M | 9.68M | 84.68M |
Year ago Sales | 0.36M | 0.04M | 0.62M | 9.68M |
Year over Year Growth Est. | -91.67% | 1,225.00% | 1,456.30% | 774.79% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.17 | -0.68 | -0.45 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.16 | -0.17 | -0.68 | -0.45 |
Low Estimate | -0.16 | -0.17 | -0.68 | -0.45 |
Year ago EPS | -0.27 | -0.28 | -0.99 | -0.68 |
Year over Year Growth Est. | 40.74% | 39.29% | 31.31% | 33.82% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.17 | -0.68 | -0.45 |
7 Days Ago | -0.16 | -0.17 | -0.68 | -0.45 |
30 Days Ago | -0.16 | -0.17 | -0.68 | -0.45 |
60 Days Ago | -0.16 | -0.17 | -0.68 | -0.38 |
90 Days Ago | -0.16 | -0.17 | -0.68 | -0.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.17 | -0.68 | -0.45 |
Zacks Consensus Estimate | -0.16 | -0.17 | -0.68 | -0.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.19 | -0.19 | -0.28 | -0.27 | NA |
Estimate | -0.18 | -0.27 | -0.26 | -0.27 | NA |
Difference | -0.01 | 0.08 | -0.02 | 0.00 | 0.01 |
Surprise | -5.56% | 29.63% | -7.69% | 0.00% | 4.10% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more